Elekta AB (OTCMKTS:EKTAY – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $5.8650, but opened at $6.23. Elekta shares last traded at $6.23, with a volume of 723 shares.
Elekta Stock Performance
The company has a quick ratio of 0.79, a current ratio of 1.04 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $2.47 billion, a P/E ratio of 95.60 and a beta of 1.07. The business has a fifty day moving average price of $6.29 and a 200-day moving average price of $5.58.
Elekta (OTCMKTS:EKTAY – Get Free Report) last issued its earnings results on Thursday, March 5th. The company reported $0.09 earnings per share for the quarter. The business had revenue of $433.29 million during the quarter. Elekta had a return on equity of 12.14% and a net margin of 1.62%. On average, sell-side analysts expect that Elekta AB will post 0.36 EPS for the current year.
Elekta Company Profile
Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.
The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.
Read More
- Five stocks we like better than Elekta
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.
